| |
| |
|
| Insider
Information: |
Barrett Elizabeth A. |
| Relationship: |
Director |
| City: |
Ra?anana |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
332,691 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,238,622 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
332,691 |
|
|
| Total
Value |
$4,238,622 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -1.2%
|
 25.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Urogen Pharma Ltd. |
URGN |
Chief Executive Officer |
2023-01-31 |
326,691 |
|
0 |
Premium* |
|
|
Science 37 Holdings, Inc |
SNCE |
Director |
2020-11-20 |
6,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• • – |
2023-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,333 |
326,691 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2022-01-31 |
4 |
S |
$7.58 |
$62,118 |
D/D |
(8,195) |
308,358 |
0 |
% |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2022-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,333 |
314,318 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2022-01-04 |
4 |
S |
$9.15 |
$429,757 |
D/D |
(46,968) |
298,220 |
0 |
% |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2022-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
105,689 |
345,188 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2021-05-19 |
4 |
D |
$17.51 |
$59,968 |
D/D |
(3,425) |
239,499 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2021-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
242,924 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2021-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,807 |
237,924 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2020-12-14 |
4 |
B |
$18.50 |
$185,000 |
D/D |
10,000 |
229,117 |
2.74 |
% |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2020-12-03 |
4/A |
OE |
$0.00 |
$0 |
D/D |
8,808 |
219,117 |
0 |
- |
|
| SNCE |
Science 37 Holdings, Inc |
Director |
– • – |
2020-11-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,000 |
|
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2020-11-03 |
4/A |
OE |
$0.00 |
$0 |
D/D |
8,808 |
210,309 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2020-10-03 |
4/A |
OE |
$0.00 |
$0 |
D/D |
8,808 |
201,501 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2020-09-03 |
4/A |
OE |
$0.00 |
$0 |
D/D |
8,807 |
192,693 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2020-08-03 |
4/A |
OE |
$0.00 |
$0 |
D/D |
8,807 |
183,886 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2020-07-03 |
4/A |
OE |
$0.00 |
$0 |
D/D |
8,807 |
175,079 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2020-06-03 |
4/A |
OE |
$0.00 |
$0 |
D/D |
8,807 |
166,272 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2020-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,229 |
157,465 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2020-05-03 |
4/A |
OE |
$0.00 |
$0 |
D/D |
8,808 |
157,465 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2020-04-03 |
4/A |
OE |
$0.00 |
$0 |
D/D |
8,807 |
148,657 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2020-03-03 |
4/A |
OE |
$0.00 |
$0 |
D/D |
8,807 |
139,850 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2020-02-03 |
4/A |
OE |
$0.00 |
$0 |
D/D |
8,807 |
131,043 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2020-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
105,688 |
122,236 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2019-11-21 |
4 |
B |
$28.00 |
$210,840 |
D/D |
7,530 |
16,548 |
2.74 |
- |
|
| URGN |
Urogen Pharma Ltd. |
Chief Executive Officer |
• – – |
2019-11-20 |
4 |
B |
$28.00 |
$209,160 |
D/D |
7,470 |
9,018 |
2.74 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
